FDA
- Status: approved
🇺🇸 Ertugliflozin 5 mg in United States
Ertugliflozin 5 mg (ertugliflozin-5-mg) regulatory status in United States.
Marketing authorisation
Pricing & reimbursement
- annual_list: USD 80000.00 per year
Ertugliflozin 5 mg in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Ertugliflozin 5 mg approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Ertugliflozin 5 mg in United States?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.
What does Ertugliflozin 5 mg cost in United States?
annual_list: USD 80000.00 per year. Final patient cost depends on reimbursement and any patient access scheme.